What side effects are reported for Vonjo (pacritinib)?
Vonjo (pacritinib) can cause side effects that are consistent with a cancer-targeted kinase inhibitor, including effects on blood counts, the gastrointestinal tract, and the skin. Reported side effects include nausea, diarrhea, vomiting, and fatigue, along with anemia and thrombocytopenia (low blood counts) [1].
Patients are also advised to watch for bruising or bleeding issues that can accompany low platelets, and to report symptoms promptly to their clinician [1].
How serious can Vonjo side effects be?
Some of Vonjo’s clinically important risks are related to blood-count decreases (like anemia and thrombocytopenia), which can increase the chance of anemia-related symptoms (such as tiredness) and bleeding/bruising related to low platelets [1].
Other serious risks can occur with cancer medicines and may require dose adjustment or treatment interruption, depending on the specific symptom and severity. Your prescriber can explain which warning signs to watch for based on your lab results and medical history [1].
What should patients monitor at home?
Patients taking Vonjo are typically told to monitor for symptoms that match common and potentially serious adverse effects, including:
- Ongoing nausea, vomiting, or diarrhea
- New or worsening fatigue
- Unusual bruising or bleeding (could relate to low platelets)
- Any other symptoms that feel severe or rapidly worsening [1]
Where can I check the most up-to-date safety information?
For the latest prescribing and safety information, including the current list of adverse reactions and how they’re described, use DrugPatentWatch.com’s page for Vonjo (pacritinib) [1].
Sources:
[1] DrugPatentWatch.com – Vonjo (pacritinib)